Kelly Thomas Patrick — SEC insider filings

SEC reporting owner CIK 1410514. 18 insider filings on record with FilingPulse; latest filed 2026-10-16.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2020-09-10 to 2026-10-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Deciphera Pharmaceuticals, Inc.Chief Financial Officer15—15 legs · 31,641 sh · $871,63028
Xenon Pharmaceuticals Inc. (XENE)Chief Financial Officer31 leg · 15,000 sh · $559,740—4

Insider filings — Kelly Thomas Patrick

FiledFormIssuerReported transactionsSource
2026-10-164Xenon Pharmaceuticals Inc. (XENE)Option exercise (M): 7,500 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2026-10-014Xenon Pharmaceuticals Inc. (XENE)Purchase (P): 15,000 @ $37.32EDGAR
2025-10-174Xenon Pharmaceuticals Inc. (XENE)Grant/award (A): 225,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-06-114Deciphera Pharmaceuticals, Inc.Grant/award (A): 34,157 · Disposition to issuer (D): 72,029 · Code (U): 42,478 · Disposition to issuer (D): 85,456 (derivative) · Disposition to issuer (D): 5,650 (derivative) · Disposition to issuer (D): 103,219 (derivative) · +4 moreEDGAR
2024-02-204Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 17,275 @ $0 · Sale (S): 3,010 @ $15.62 · Grant/award (A): 69,100 (derivative) @ $0EDGAR
2024-01-184Deciphera Pharmaceuticals, Inc. (DCPH)Sale (S): 2,435 @ $14.47EDGAR
2023-12-144Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 8,244 · Sale (S): 2,792 @ $15.37EDGAR
2023-10-314Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 8,244 · Sale (S): 2,316 @ $12.02EDGAR
2023-06-214Deciphera Pharmaceuticals, Inc. (DCPH)Sale (S): 1,655 @ $14.40EDGAR
2023-02-174Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 16,488 @ $0 · Sale (S): 1,370 @ $15.10 · Grant/award (A): 65,900 (derivative) @ $0EDGAR
2023-01-194Deciphera Pharmaceuticals, Inc. (DCPH)Sale (S): 2,403 @ $21.24EDGAR
2022-06-214Deciphera Pharmaceuticals, Inc. (DCPH)Sale (S): 1,768 @ $10.75EDGAR
2022-02-184Deciphera Pharmaceuticals, Inc. (DCPH)Sale (S): 1,368 @ $9.05EDGAR
2022-01-204Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 20,500 @ $0 · Grant/award (A): 82,000 (derivative) @ $0EDGAR
2021-12-174Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 11,100 @ $0 · Grant/award (A): 82,265 (derivative) @ $0EDGAR
2021-02-184Deciphera Pharmaceuticals, Inc. (DCPH)Sale (S): 524 @ $48.87 · Grant/award (A): 11,100 @ $0 · Grant/award (A): 49,900 (derivative) @ $0EDGAR
2020-09-164Deciphera Pharmaceuticals, Inc. (DCPH)Option exercise (M): 3,000 @ $1.89 · Sale (S): 3,000 @ $50.01 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2020-09-104Deciphera Pharmaceuticals, Inc. (DCPH)Option exercise (M): 6,000 @ $1.89 · Sale (S): 800 @ $44.69 · Sale (S): 3,700 @ $45.23 · Sale (S): 1,500 @ $46.55 · Option exercise (M): 3,000 @ $1.89 · Sale (S): 3,000 @ $47.71 · +2 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1410514 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs